- Release Date: 04/07/23 08:38
- Summary: Acrux's seventh generic dossier accepted by FDA for review
- Price Sensitive: Yes
- Download Document 136.02KB
Ann: Acrux's seventh generic dossier accepted by FDA for review
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.002(3.23%) |
Mkt cap ! $18.02M | |||
| Open | High | Low | Value | Volume |
| 6.2¢ | 6.4¢ | 6.2¢ | $6.853K | 110.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 102577 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 6973 | 2 |
View Market Depth
| Last trade - 15.32pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.4¢ |
Change
0.002 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| 6.4¢ | 6.4¢ | 6.4¢ | 461 | ||
| Last updated 15.54pm 08/05/2024 ? | |||||
| ACR (ASX) Chart |